Unity Health Toronto

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Unity Health Toronto sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials 2 currently recruiting 9 completed later-stage tilt top decile by trial count

Unity Health Toronto: 12 sponsored US clinical trials, 2 recruiting.

Unity Health Toronto sponsors 12 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 9 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Bypass Graft Surgery, with 1 trials.

Top-decile sponsor footprint

Unity Health Toronto ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

12 total, page 1 of 1

RECRUITING NA

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

NCT04754022
RECRUITING NA

Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)

NCT03963622
ACTIVE NOT RECRUITING

Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia

NCT01158807
COMPLETED Phase 4

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

NCT03900026
COMPLETED NA

Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial)

NCT02568722
COMPLETED NA

Evaluation of Laparoscopic Hysterectomy Simulator

NCT02234856
COMPLETED NA

Transfusion Requirements in Cardiac Surgery III

NCT02042898
COMPLETED

Mechanical Ventilation Discontinuation Practices

NCT03955874
COMPLETED NA

Clinician JUdgment Versus Risk Score to Predict Stroke outComes: The JURASSIC Clinical Trial

NCT01657279
COMPLETED Phase 4

Treating Acutely Agitated Patients With Asenapine Sublingual Tablets

NCT01400113
COMPLETED NA

Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department

NCT01193998
COMPLETED NA

Stress Reduction in Older Women With Stage II, Stage III, or Stage IV Breast Cancer

NCT00006346

Phase Distribution

PhaseTrial count
Phase 4 2

Therapeutic Areas

Coronary Artery Bypass Graft Surgery 1
Psychosocial Effects of Cancer and Its Treatment 1
Post Operative 1
Shortness of Breath 1
Vein Occlusion 1
Acute Heart Failure 1
Dyspnea 1
Hereditary Hemorrhagic Telangiectasia 1
Atherosclerosis 1
Cardiac Surgery 1

Where Unity Health Toronto enrollment is open (later-stage tilt)

2 recruiting of 12 indexed (17% open); 9 completed (75%).

Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Coronary Artery Bypass Graft Surgery (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Unity Health Toronto: open-pipeline peers nationwide

Peers matched on 12 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

Unity Health Toronto sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 468101214 0%5%10%15%20% Total trials Recruiting share Unity Health TorontoAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.AngiodynamicsAdageneAgendiaAkamis BioAnthos Therapeutics
Unity Health Toronto sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Unity Health Toronto sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Unity Health Toronto page

12 registered trials is a research-attention snapshot, not an endorsement of Unity Health Toronto or any single study.

  • 2 of Unity Health Toronto's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Coronary Artery Bypass Graft Surgery is the condition Unity Health Toronto studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Bypass Graft Surgery trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Unity Health Toronto pipeline card: 12 registered trials from official public datasets.Report a data error.